Instead of nursing hangovers or sleeping in, the eight Northwestern University law students in Paul Chadha’s class have been spending their Saturday mornings hashing out a complex business deal.
The students taking International Business Law and Negotiations are representing KHJ Pharmaceuticals, a fictional drug company that is attempting to establish a supply of cassava extract — a key ingredient in a new drug the company hopes to manufacture — from a consortium of farmers in the made-up African nation of Malundia.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
